This guide educates substance use counselors and clinicians about detoxification and withdrawal. It addresses patient placement, detox services for specific substances, co-occurring disorders, financing issues, and screening and assessment tools.
Dashboard: Filter Bricks
Main page content
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep15-fedguideotp.jpg?itok=X-44P8_n)
This manual provides guidelines for the operation of opioid treatment programs. It covers patient assessment, treatment planning, and recovery care. The manual also offers guidance for medication-assisted treatment for methadone and buprenorphine, and overdose and relapse prevention.
![Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence](/sites/default/files/styles/product_thumbnail_dashboard/public/sma12-4682.jpg?itok=GVcM1MdW)
This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.
![Protracted Withdrawal](/sites/default/files/styles/product_thumbnail_dashboard/public/sma10-4554.jpg?itok=HRB-WXly)
This advisory defines protracted withdrawal and identifies specific withdrawal symptoms associated with alcohol, opioids, methamphetamine, cocaine, marijuana, and benzodiazepines. The advisory also explains how protracted withdrawal differs from acute withdrawal, and gives tips to help clients manage it in recovery.